181 related articles for article (PubMed ID: 25337407)
1. Lung cancer. Radiotherapy in lung cancer: Actual methods and future trends.
Maciejczyk A; Skrzypczyńska I; Janiszewska M
Rep Pract Oncol Radiother; 2014 Nov; 19(6):353-60. PubMed ID: 25337407
[TBL] [Abstract][Full Text] [Related]
2. Adaptive Dose Escalation using Serial Four-dimensional Positron Emission Tomography/Computed Tomography Scans during Radiotherapy for Locally Advanced Non-small Cell Lung Cancer.
Yap ML; Sun A; Higgins J; Clarke K; Marshall A; Becker N; Le LW; Vines DC; Bezjak A; Bissonnette JP
Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):e199-e205. PubMed ID: 27637725
[TBL] [Abstract][Full Text] [Related]
3. Technical and dosimetric implications of respiratory induced density variations in a heterogeneous lung phantom.
Mohatt DJ; Ma T; Wiant DB; Islam NM; Gomez J; Singh AK; Malhotra HK
Radiat Oncol; 2018 Sep; 13(1):165. PubMed ID: 30180894
[TBL] [Abstract][Full Text] [Related]
4. A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.
Li G; Cohen P; Xie H; Low D; Li D; Rimner A
Phys Med Biol; 2012 Nov; 57(22):7579-98. PubMed ID: 23103415
[TBL] [Abstract][Full Text] [Related]
5. Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapy.
Martin S; Johnson C; Brophy M; Palma DA; Barron JL; Beauchemin SS; Louie AV; Yu E; Yaremko B; Ahmad B; Rodrigues GB; Gaede S
Acta Oncol; 2015 Mar; 54(3):322-32. PubMed ID: 25350526
[TBL] [Abstract][Full Text] [Related]
6. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
Liao ZX; Komaki RR; Thames HD; Liu HH; Tucker SL; Mohan R; Martel MK; Wei X; Yang K; Kim ES; Blumenschein G; Hong WK; Cox JD
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):775-81. PubMed ID: 19515503
[TBL] [Abstract][Full Text] [Related]
7. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
Fleckenstein J; Kremp K; Kremp S; Palm J; Rübe C
Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of using intravenous contrast-enhanced computed tomography (CT) scans in lung cancer treatment planning.
Xiao J; Zhang H; Gong Y; Fu Y; Tang B; Wang S; Jiang Q; Li P
Radiother Oncol; 2010 Jul; 96(1):73-7. PubMed ID: 20347496
[TBL] [Abstract][Full Text] [Related]
9. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
10. Comparison of planned dose on different CT image sets to four-dimensional Monte Carlo dose recalculation using the patient's actual breathing trace for lung stereotactic body radiation therapy.
Freislederer P; von Münchow A; Kamp F; Heinz C; Gerum S; Corradini S; Söhn M; Reiner M; Roeder F; Floca R; Alber M; Belka C; Parodi K
Med Phys; 2019 Jul; 46(7):3268-3277. PubMed ID: 31074510
[TBL] [Abstract][Full Text] [Related]
11. Effects of reconstruction methods on dose distribution for lung stereotactic body radiotherapy treatment plans.
Yedekci Y; Hurmuz P; Ozyigit G
Radiat Environ Biophys; 2023 Mar; 62(1):107-115. PubMed ID: 36526911
[TBL] [Abstract][Full Text] [Related]
12. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
13. Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center.
Rosen LR; Fischer-Valuck BW; Katz SR; Durci M; Wu HT; Syh J; Syh J; Patel B
Tumori; 2014; 100(1):42-8. PubMed ID: 24675490
[TBL] [Abstract][Full Text] [Related]
14. Role of computed tomography and [18F] fluorodeoxyglucose positron emission tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiation.
Ceresoli GL; Cattaneo GM; Castellone P; Rizzos G; Landoni C; Gregorc V; Calandrino R; Villa E; Messa C; Santoro A; Fazio F
Tumori; 2007; 93(1):88-96. PubMed ID: 17455878
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of four-dimensional computed tomography based internal target volume against variations in respiratory motion during treatment between volumetric modulated arc therapy and three-dimensional conformal radiotherapy in lung stereotactic body radiotherapy.
Fujimoto D; Takatsu J; Hara N; Oshima M; Tomihara J; Segawa E; Inoue T; Shikama N
Radiol Phys Technol; 2024 Mar; 17(1):143-152. PubMed ID: 37930563
[TBL] [Abstract][Full Text] [Related]
17. [The use of PET/CT in radiotherapy of patients with non-small cell lung cancer].
Lõcsei Z; Hideghéty K; Farkas R; Bellyei S; Sárosi V; Sebestyén K; Sebestyén Z; Kovács P; Mangel L
Magy Onkol; 2011 Nov; 55(4):274-80. PubMed ID: 22128310
[TBL] [Abstract][Full Text] [Related]
18. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.
Lambrecht M; Melidis C; Sonke JJ; Adebahr S; Boellaard R; Verheij M; Guckenberger M; Nestle U; Hurkmans C
Radiat Oncol; 2016 Jan; 11():7. PubMed ID: 26791788
[TBL] [Abstract][Full Text] [Related]
19. Automatically gated image-guided breath-hold IMRT is a fast, precise, and dosimetrically robust treatment for lung cancer patients.
Simeonova-Chergou A; Jahnke A; Siebenlist K; Stieler F; Mai S; Boda-Heggemann J; Wenz F; Lohr F; Jahnke L
Strahlenther Onkol; 2016 Mar; 192(3):166-73. PubMed ID: 26780654
[TBL] [Abstract][Full Text] [Related]
20. Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions.
Dvorak P; Georg D; Bogner J; Kroupa B; Dieckmann K; Pötter R
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1572-81. PubMed ID: 15817364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]